Cipro Suspension/ Drops
NDC Package 76420-273-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cipro (ciprofloxacin hydrochloride and hydrocortisone) suspension/ dropses is a medication used to treat a variety of bacterial infections. This formulation utilizes a suspension/ drops delivery system. Marketed by Asclemed Usa, Inc., this product is identified by NDC 76420-273 and is authorized under FDA application NDA020805.

Identification & Billing

NDC Package Code
76420-273-10
Package Description
10 mL in 1 BOTTLE
Product Code
76420-273
11-Digit Billing Format
76420027310
RxNorm Crosswalk
  • RxCUI: 213320 - Cipro HC 0.2 % / 1 % Otic Suspension
  • RxCUI: 213320 - ciprofloxacin 2 MG/ML / hydrocortisone 10 MG/ML Otic Suspension [Cipro HC]
  • RxCUI: 213320 - Cipro HC (ciprofloxacin 0.2 % / hydrocortisone 1 % ) Otic Suspension
  • RxCUI: 213320 - Cipro HC 2/10 Otic Suspension
  • RxCUI: 309305 - ciprofloxacin 0.2 % / hydrocortisone 1 % Otic Suspension

Clinical Specifications

Proprietary Name
Cipro HC
Non-Proprietary Name
Ciprofloxacin Hydrochloride And Hydrocortisone
Substance Name
Ciprofloxacin Hydrochloride; Hydrocortisone
Dosage Form
Suspension/ Drops - A suspension which is usually administered in a dropwise fashion.
Administration Route
Auricular (otic) - Administration to or by way of the ear.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Asclemed Usa, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA020805
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-15-1999
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76420-273-10 identifies a specific commercial package of 10 ml in 1 bottle of Cipro HC, a human prescription drug labeled by Asclemed Usa, Inc.. This suspension/ drops is formulated for auricular (otic) use and contains ciprofloxacin hydrochloride; hydrocortisone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Asclemed Usa, Inc. on March 15, 1999. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Asclemed Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76420027310. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76420-273-10
11-Digit CMS (5-4-2)
76420-0273-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.